Search clinical trials for: bph

Total 390 results

Urovant Sciences GmbH

Completed

Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Overactive Bladder

United States, Poland
University of Helsinki

Active, not recruiting

KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients

BPH (Benign Prostatic Hyperplasia)

Finland
En Chu Kong Hospital

Completed

The Changes of Urine Growth Factors Level

Benign Prostatic Hyperplasia

Taiwan
Children's Cancer Hospital Egypt 57357

Completed

Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.

Osteosarcoma | Ewing Sarcoma of Bone

Egypt
Chinese University of Hong Kong

Active, not recruiting

To Linguistically and Psychometrically Validate the Hong Kong Chinese Version of the BPH 3-item Questionnaire

Benign Prostatic Hyperplasia (BPH)

Hong Kong
Lawson Health Research Institute

Completed

5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression

Depression | Suicide | BPH
University of Florida
National Institute on Aging (NIA)

Active, not recruiting

The PACE-DLB Study

Dementia With Lewy Bodies

United States
Boston University
United States Agency for International Development (USAID); Pharmaceutical...

Completed

Evaluating the Efficacy of Using a Digital Consumption Management Tool for Family Planning in Zambia

Family Planning

Zambia
Merit Medical Systems, Inc.

Completed

Embosphere® PROstate Post Market Study (PROstate)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States, United Kingdom, Italy, France
Comenius University

Completed

Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overactive Bladder (SILODOSING)

Overactive Bladder | Benign Prostatic Hyperplasia (BPH)

Slovakia
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation; ViiV Healthcare

Active, not recruiting

Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa (AXIS)

HIV Infections

South Africa
Northwestern University

Completed

Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH)

United States
Thunder Bay Regional Health Research Institute
Northern Ontario School of Medicine

Active, not recruiting

Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada
Boston Scientific Corporation

Completed

China Greenlight Registry Study (Post-market)

Benign Prostatic Hyperplasia (BPH)

China
HistoSonics, Inc.

Terminated

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)

Benign Prostatic Hyperplasia (BPH)

United States
Ain Shams University

Completed

The Clinical Efficacy of Rezūm Therapy Versus Bipolar Trans-urethral Resection of the Prostate for Treatment Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Egypt
Medi-Tate Ltd.

Active, not recruiting

Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH (MT-06)

BPH

France, Italy, Germany, Australia, Spain, Switzerland
Weill Medical College of Cornell University
Teleflex; NeoTract, Inc.

Suspended

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Benign Prostatic Hyperplasia

United States
Weill Medical College of Cornell University
Boston Scientific Corporation

Suspended

Catheterless Water Vapor Therapy for the Treatment of BPH

Benign Prostatic Hyperplasia

United States
Northwestern University
BTG International Inc.

Completed

Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres

Benign Prostatic Hyperplasia (BPH)

United States
Race Oncology Ltd
Astex Pharmaceuticals, Inc.

Withdrawn

A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS (BISECT)

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic Syndrome

Australia
Urovant Sciences GmbH

Completed

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Overactive Bladder

United States, Spain, Canada, Portugal, Poland, Belgium, Hungary, Lithuania
SIFI SpA

Completed

Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis

Acanthamoeba Keratitis

Italy, United Kingdom, Poland
Helwan University

Active, not recruiting

Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Egypt
Urotronic Inc.

Active, not recruiting

Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter (EVEREST-I)

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Dominican Republic, Panama
PROCEPT BioRobotics

Completed

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) (WATER)

Benign Prostatic Hyperplasia (BPH)

United States, Australia, United Kingdom, New Zealand
PROCEPT BioRobotics

Completed

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II (WATERII)

Benign Prostatic Hyperplasia (BPH)

United States, Canada
Claudia Luévano-Contreras

Completed

Black Bean (Phaseolus Vulgaris L.) Protein Hydrolysates Reduce Acute Postprandial Glucose Levels

PreDiabetes

Mexico
Menoufia University

Completed

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Prostatic Neoplasms | Prostate Disease | Prostate Hypertrophy | Prostate Obstruction

Egypt
Murdoch Childrens Research Institute

Completed

Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1

Hypertension | Blood Pressure | Neurofibromatosis 1

Australia
Mansoura University

Completed

Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study

BPH

Egypt
ProArc Medical

Completed

Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia

Benign ProstaticHyperplasia (BPH)

Israel, Latvia
Indiana Kidney Stone Institute

Active, not recruiting

Laser Prostatectomy Database and Registry

Benign Prostatic Hyperplasia | Enlarged Prostate

United States
San Carlo di Nancy Hospital
Elesta S.R.L.

Completed

Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy | Benign Prostatic Hypertrophy With Outflow Obstruction | Prostate Hyperplasia

Italy
Urological Research Network, LLC

Active, not recruiting

Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA

Prostatic Hyperplasia | Male Urogenital Diseases | Genital Diseases, Male | Prostatic Disease

United States
The Methodist Hospital Research Institute

Completed

Brain Imaging in Men With Lower Urinary Tract Symptoms

Voiding Disorders

United States
Assiut University

Completed

HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study

Benign Prostatic Hyperplasia (BPH)

Egypt
Centre hospitalier de l'Université de Montréal...

Completed

Simulation-Based Enucleation Training: Initial Experience Using 3D-printed Organ Phantoms

BPH

Canada
Urotronic Inc.
ClinLogix. LLC

Active, not recruiting

A Clinical Study to Evaluate the Safety and Efficacy of the Optilume™ BPH Catheter System in Men With Symptomatic BPH (PINNACLE)

Benign Prostatic Hyperplasia

United States, Canada
GemVax & Kael

Completed

Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
University Hospitals Cleveland Medical Center
Sanofi

Completed

Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)

Erectile Dysfunction | BPH

United States
Mansoura University

Active, not recruiting

Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB

Overactive Bladder | Benign Prostatic Hyperplasia

Egypt
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | BPH

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia

Benign Prostate Hyperplasia

Japan
Helwan University

Completed

Prostate Bipolar Enucleation and Resection Versus Open Prostatectomy

Benign Prostatic Hyperplasia

Egypt
RECORDATI GROUP

Terminated

Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH

Lower Urinary Tract Symptoms

Spain, United Kingdom, Italy, Germany, Poland
Benha University

Completed

Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH

Prostatic Hyperplasia | Prostatic Hypertrophy, Benign | Prostate Obstruction

Egypt
Medi-Tate Ltd.

Completed

Study to Assess the Efficacy of Medi-Tate iTind Device

Benign Prostatic Hyperplasia (BPH)

Spain, Belgium, Italy, Switzerland, United Kingdom
GemVax & Kael

Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Boston Scientific Corporation

Completed

To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China

Benign Prostatic Hyperplasia (BPH)

China

Search clinical trials for: bph

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations